Therefore, in this study, we used Sequenom Mass ARRAY technology to perform high-throughput analysis of CX3CL1 and CX3CR1 gene polymorphisms, aiming to explore the effect of CX3CL1 and CX3CR1 gene polymorphisms on the clinical efficacy of carboplatin in the treatment of ovarian cancer. This evidence concerns the gene CX3CL1 and ovarian carcinoma.